相关实验视频
Updated: Jul 28, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
977
稳定冠状动脉疾病患者的不成熟血小板和心血管事件
Oliver Buchhave Pedersen1,2,3, Sanne Bøjet Larsen2, Steen Dalby Kristensen2,3
1Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
Platelets
|May 29, 2023
概括
不成熟的血小板标志物不能预测稳定的冠状动脉疾病 (CAD) 患者的心血管事件. 这项研究发现,在CAD患者中,不成熟的血小板和未来的心脏病发作或中风之间没有联系.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 血小板生物学 血小板生物学
背景情况:
- 冠状动脉疾病 (CAD) 患者的阿司匹林耐药性可能与不成熟的血小板有关.
- 了解心血管事件的预测因素对于患者管理至关重要.
研究的目的:
- 调查是否不成熟的血小板标志物可以预测稳定的CAD患者的心血管事件.
- 评估各种不成熟的血小板指数与不良心血管结果之间的关系.
主要方法:
- 一组900名稳定的CAD患者被跟踪了3年的中位数.
- 使用自动流动细胞计测量不成熟的血小板标记物 (例如,不成熟的血小板分数,平均血小板体积).
- 心血管事件 (心肌梗塞,缺血性中风,心血管死亡) 被追踪为主要和次要终点.
主要成果:
- 在经历心血管事件的患者和没有经历心血管事件的患者之间,没有观察到不成熟的血小板标志物的显著差异.
- 危险率回归分析表明,不成熟的血小板标记物对于研究的终点缺乏预测价值 (p > .05).
- 不成熟的血小板标志物在3年随访期间没有显示出对未来心血管事件的预测能力.
结论:
- 不成熟的血小板标记物似乎不是稳定的CAD患者未来心血管事件的主要预测因素.
- 在稳定的CAD中,不成熟血小板在阿司匹林反应或心血管风险方面发挥的作用需要进一步研究.
- 这些发现表明,在稳定阶段不成熟的血小板测量可能在临床上对CAD风险分层不有用.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
570
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
570
Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K
Structure and Function of Platelets
1.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.3K
Coronary Artery Disease II: Pathophysiology
16
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
16
Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
773
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
773

